MoneyWorks4Me

Mercury Laboratories - Quaterly Results

24 Jul 2024 Evaluate
The sales declined to Rs. 166.77 millions for the June 2024 quarter as compared to Rs. 183.22 millions during the corresponding quarter last year.A big decline of -65.80% was reported for the quarter ended June 2024 to Rs. 3.42  millions from Rs. 10.00 millions of corresponding previous quarter.Operating profit for the quarter ended June 2024 decreased to 17.56 millions as compared to 18.06 millions of corresponding quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 166.77 183.22 -8.98 166.77 183.22 -8.98 755.59 753.34 0.30
Other Income 1.50 1.45 3.45 1.50 1.45 3.45 10.88 17.19 -36.71
PBIDT 17.56 18.06 -2.77 17.56 18.06 -2.77 101.20 102.90 -1.65
Interest 1.38 0.75 84.00 1.38 0.75 84.00 3.83 3.62 5.80
PBDT 16.18 17.31 -6.53 16.18 17.31 -6.53 97.37 99.28 -1.92
Depreciation 6.98 6.75 3.41 6.98 6.75 3.41 28.16 24.83 13.41
PBT 9.20 10.56 -12.88 9.20 10.56 -12.88 69.21 74.45 -7.04
TAX 5.78 0.56 932.14 5.78 0.56 932.14 12.66 18.66 -32.15
Deferred Tax 1.78 -2.94 -160.54 1.78 -2.94 -160.54 -6.34 -3.38 87.57
PAT 3.42 10.00 -65.80 3.42 10.00 -65.80 56.55 55.79 1.36
Equity 12.00 12.00 0.00 12.00 12.00 0.00 12.00 12.00 0.00
PBIDTM(%) 10.53 9.86 6.82 10.53 9.86 6.82 13.39 13.66 -1.95
Peers
Company Name CMP
Sun Pharma. Inds. 1843.55
Dr. Reddys Labs. 1245.20
Cipla 1386.55
Lupin 2081.70
Zydus Lifesciences 1215.00
View more..